Auxilium Pharmaceuticals Inc (AUXL.OQ)

AUXL.OQ on NASDAQ Stock Exchange Global Select Market

34.70USD
19 Dec 2014
Price Change (% chg)

$0.68 (+1.98%)
Prev Close
$34.03
Open
$33.85
Day's High
$35.03
Day's Low
$33.85
Volume
1,372,838
Avg. Vol
539,242
52-wk High
$35.03
52-wk Low
$17.11

AUXL.OQ

Chart for AUXL.OQ

About

Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company focuses on developing and marketing products to predominantly specialist audiences. It market two products: Testim testosterone gel and XIAFLEX (collagenase clostridium histolyticum). XIAFLEX is an injectable clostridial collagenase enzyme approved by the... (more)

Overall

Beta: 0.66
Market Cap (Mil.): $1,770.45
Shares Outstanding (Mil.): 51.02
Dividend: --
Yield (%): --

Financials

  AUXL.OQ Industry Sector
P/E (TTM): -- 37.83 38.47
EPS (TTM): -3.27 -- --
ROI: -17.27 18.99 18.25
ROE: -73.36 19.75 19.13
Search Stocks

Endo profit beats estimates on strong generic drug sales

Nov 5 - Endo International Plc, which is acquiring Auxilium Pharmaceuticals Inc, reported a better-than-expected quarterly profit due to a nearly 74 percent jump in sales of its generic drugs in the United States.

05 Nov 2014

Deals of the day-Mergers and acquisitions

(Baidu, Lloyds, Serco, Deutsche Boerse, Cytotools, AquaChile, Riverbed, Big Bus Tours)

09 Oct 2014

Endo bolsters men's healthcare business with Auxilium deal

- Endo International Plc brought a successful end to its month-long pursuit of Auxilium Pharmaceuticals Inc , with the smaller rival choosing a sweetened offer over its agreement to buy Canadian eye-drug maker QLT Inc .

09 Oct 2014

UPDATE 2-Endo bolsters men's healthcare business with Auxilium deal

* Endo shares down 5 pct (Adds analyst comments, background; updates shares)

09 Oct 2014

Endo to buy Auxilium for $2.6 bln, Auxilium drops QLT deal

Oct 9 - Endo International Plc said it would buy Auxilium Pharmaceuticals Inc in a deal valued at $2.6 billion, including the repayment and assumption of debt.

09 Oct 2014

Deals of the day- Mergers and acquisitions

(Adds Silver Lake, EEX, Exxon, Santander, Sun Resorts, Otter Media and Rexel; updates Total and Auxilium)

22 Sep 2014

Auxilium says Endo offer undervalues company, but open to talks

- Auxilium Pharmaceuticals Inc said its board had determined that Endo International Plc's $2.2 billion takeover offer "significantly undervalues" the company, but left the door open for talks on a possible deal.

22 Sep 2014

UPDATE 2-Auxilium says Endo offer undervalues company, but open to talks

* Endo's shares down 1 pct; Auxilium's shares down 0.7 pct (Adds Endo's response)

22 Sep 2014

Auxilium says Endo's offer "significantly undervalues" company

Sept 22 - Auxilium Pharmaceuticals Inc said its board had determined that Endo International Plc's offer "significantly undervalues" the company.

22 Sep 2014

US STOCKS-Auxilium jumps, steelmakers active in premarket trade

* Futures off: Dow 8 pts, S&P 1.5 pts, Nasdaq 6 pts (Adds trading in steelmakers, Auxilium)

17 Sep 2014

Competitors

  Price Change
Repros Therapeutics Inc (RPRX.OQ) $9.15 +0.28
Eli Lilly and Co (LLY.N) $72.40 -0.05
AbbVie Inc (ABBV.N) $67.71 -0.21

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Jefferson Research
$20.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks